Disease Overview：Restless Legs Syndrome（RLS）
Restless Legs Syndrome (RLS), also known as Willis–Ekbom Disease, is a chronic neurological sensorimotor disorder characterized by an irresistible urge to move the legs—typically accompanied by uncomfortable, non-painful sensations such as crawling, tingling, or aching—worsening during rest and evening/night hours, and temporarily relieved by movement. Prevalence ranges from 5% to 10% globally, with higher incidence in older adults and individuals with iron deficiency, renal failure, pregnancy, or Parkinson’s disease. Diagnosis relies on clinical criteria (International Restless Legs Syndrome Study Group criteria), supported by polysomnography, serum ferritin assessment, and exclusion of mimics like peripheral neuropathy or venous insufficiency. First-line management includes iron repletion (IV or oral) for ferritin <75 µg/L, followed by dopamine agonists (e.g., pramipexole, ropinirole), alpha-2-delta ligands (e.g., gabapentin enacarbil), or low-dose opioids in refractory cases. Long-term treatment requires careful monitoring for augmentation and impulse control disorders.
China offers distinct advantages for RLS care: leading neurology centers—such as Beijing Tiantan Hospital and Shanghai Huashan Hospital—feature multidisciplinary RLS clinics staffed by specialists trained in movement disorders and sleep neurology. Advanced diagnostics include high-resolution nerve conduction studies, quantitative sensory testing, and functional MRI for central dopaminergic pathway evaluation. Over 85% of patients receiving protocol-driven iron repletion plus neuromodulatory therapy report ≥50% symptom reduction within 12 weeks, per recent multicenter registry data. Treatment costs are typically 40–60% lower than in the US or EU, without compromising evidence-based protocols or medication quality. As a dedicated medical tourism agency, we facilitate seamless access to these resources—handling hospital referrals, coordinating pre-arrival diagnostic workups, providing transparent all-inclusive pricing (consultation, labs, therapy, accommodation), and offering bilingual support throughout the care journey.
Restless Legs Syndrome: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Restless Legs Syndrome (RLS) — Neurology Department
I. Non-Surgical / Conservative / Medication Options
*Target criteria:* Mild-to-moderate RLS (IRLSSG score <20), no secondary causes (e.g., iron deficiency, renal failure, neuropathy).
- •First-line pharmacotherapy
- *Ropinirole (0.25–4 mg/day)*: ¥220–¥410/month ($31–$57) - *Rotigotine patch (1–3 mg/24h)*: ¥680–¥1,250/month ($95–$175)
- •Adjunctive & supportive care
- *Polysomnography (PSG) for comorbid sleep apnea*: ¥1,400–¥2,200 ($195–$310) - *Neurological exam + nerve conduction study (NCS)*: ¥320 ($45)
II. Surgical / Procedural / Interventional Options
*Eligibility criteria:* Refractory RLS (IRLSSG ≥25), confirmed dopaminergic augmentation, exclusion of secondary causes, failed ≥2 medication classes + behavioral therapy. *No surgical procedure is FDA/CFDA-approved for primary RLS.* All interventions are off-label or investigational; performed only in tertiary neurology centers with multidisciplinary review.
- •Deep brain stimulation (DBS) — subthalamic nucleus (STN)
- Procedure (implantation + programming): ¥185,000–¥240,000 ($25,900–$33,600) - Battery replacement (every 5–7 years): ¥42,000–¥58,000 ($5,900–$8,100)
- •Spinal cord stimulation (SCS) — investigational for refractory RLS
- Permanent implant (if >50% symptom reduction): ¥158,000–¥192,000 ($22,100–$26,900)
III. Special / Complex Condition Management
- •*Pregnancy-associated RLS*: Non-pharmacologic only (magnesium glycinate ¥90/month; $13); acupuncture (neurology-department supervised, 10 sessions) ¥2,100 ($295)
- •*Uremic RLS (CKD Stage 4–5)*: IV iron + optimized hemodialysis + gabapentin enacarbil (if available) ¥540/month ($76)
- •*Augmentation syndrome*: Dopamine agonist withdrawal + α₂δ ligand switch: pregabalin ¥260–¥440/month ($36–$62)
Quick Selection Guide
- •<50 years, mild symptoms, budget < $100/mo: Ferritin test + oral pramipexole + sleep hygiene → $25–$45/mo
- •60+ years, moderate-severe, comorbid CKD/diabetes: IV iron + gabapentin + NCS/PSG workup → $195–$310 initial, $76/mo ongoing
- •Refractory, augmentation, no contraindications, annual budget > $25,000: DBS evaluation pathway → $25,900–$33,600 one-time
- •Pregnant or lactating: Magnesium + supervised acupuncture → $13–$295 total
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Restless Legs Syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Restless Legs Syndrome treatment with China top medical destinations:
